EXPRESS: Real-World Experience With Riociguat as Potential Bridging Therapy in Patients With Chronic Thromboembolic Pulmonary Hypertension: A Case Series

Pulmonary Circulation - United States
doi 10.1177/2045894019898377
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

EXPRESS: Circulating Biomarkers in Chronic Thromboembolic Pulmonary Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2019English

Prevelance of Pulmonary Atherosclerosis in Patients With Chronic Thromboembolic Pulmonary Hypertension

American Journal of Cardiovascular and Thoracic Surgery
2017English

Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension

Annals of the American Thoracic Society
PulmonaryRespiratory Medicine
2016English

Riociguat Is a Novel Medication for the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Medical Council
2016English

Refined Balloon Pulmonary Angioplasty for Inoperable Patients With Chronic Thromboembolic Pulmonary Hypertension

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2012English

Chronic Thromboembolic Pulmonary Hypertension

2010English

Chronic Thromboembolic Pulmonary Hypertension

2020English

Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center

Cardiology and Therapy
2015English

Chronic Thromboembolic Pulmonary Hypertension

Seminars in Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy